Abstract
KRN2391 is potassium channel opener with a nitrate moiety which possesses potent vasodilatory action. The hemodynamic profiles of KRN2391-induced hypotension are still not well understood. The aim of this study was to investigate the potential use of KRN2391 for induced hypotension. Eight dogs were anesthetized with 0.87% halothane in oxygen (1 MAC). After the baseline period, mean arterial pressure (MAP) was reduced to 60 mmHg for 60 min by the infusion of KRN2391. MAP was reduced approximately 50% and was associated with a 80% maximum reduction (P<0.01) in systemic vascular resistance but was not accompanied by a significant change in heart rate. Hypotension induced by KRN2391 was associated with a 224% maximum increase (P<0.01) in cardiac index (CI) and a 136% maximum increase (P<0.01) in stroke volume index (SVI) during induced hypotension. Both CI and SVI remained significantly increased after the termination of drug infusion. Left ventricular maximum dP/dt increased significantly during and after induced hypotension. Right atrial and mean pulmonary artery pressures increased significantly, whereas pulmonary capillary wedge pressure remained unchanged. The results of the present study show that KRN2391 is effective in reducing afterload during induced hypotension, and suggest that the hemodynamic profiles of KRN2391-induced hypotension are a hyperdynamic state as expressed by twofold increases in CI concomitant with the increase in right ventricular filling pressures.
Similar content being viewed by others
References
Kashiwabara T, Nakajima S, Izawa T, Fukushima H, Nishikori K (1991) Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta. Eur J Pharmacol 196:1–7
Ishibashi T, Hamaguchi M, Imai S (1992) Vasodilating properties of KRN2391: structural basis of a new pyridine-type potassium channel opener with a nitrate moiety. Naunyn-Schmiedeberg's Arch Pharmacol 346:94–101
Ogawa N, Fukata Y, Kaneta S, Jinno Y, Fukushima H, Nishikori K (1992) Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. J Cardiovasc Pharmacol 20:11–17
Taira N (1987) Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview. J Cardiovasc Pharmacol 10[Suppl VIII]:S1-S9
Taira N (1989) Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63:18J-24J
Takeda S, Inada Y, Ozawa Y, Nakamizo N, Tomaru T (1995) Hemodynamic effects of KRN2391 (potassium channel opener) in halothane-anesthetized dogs. J Anesth 9:176–181
Ogawa N, Kaneta S, Jinno Y, Kasai H, Nishikori K, Fukushima H (1992) Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs. Arch Int Pharmacodyn 318:36–46.
Jinno Y, Kasai H, Ohta H, Nishikori K, Fukushima H, Ogawa N (1992) Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig. Br J Pharmacol 106:906–909
Weir SW, Weston AH (1986) The effets of BRL34915 and nicorandil on electrical and mechanical activity and on86Rb efflux in rat blood vessels. Br J Pharmacol 88:121–128
Eltze M (1989) Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP49356 in guinea-pig pulmonary artery. Eur J Pharmacol 165:231–239
Ogawa N, Jinno Y, Kaneta S, Harada K, Fukata Y, Fukushima H (1993) Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs. J Cardiovasc Pharmacol 21:874–882
Gotanda K, Yokoyama H, Satoh K, Taira N (1989) Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel opener, in the dogs, special reference to venous return. Cardiovasc Drugs Ther 3:507–515
Kaneta S, Jinno Y, Miwa A, Fukushima H, Ogawa N (1993) Effect of KRN2391 on venous return: comparison with other vasodilators. J Cardiovasc Pharmacol 22:82–88
Ogilvie RI (1978) Effect of nitroglycerin on peripheral blood flow distribution and venous return. J Pharmacol Exp Ther 207:372–380
Kaneta S, Yokoyama T, Izumi H, Izawa T, Ogawa N (1994) Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin. Arch Int Pharmacodyn 327:184–193
Kashiwabara T, Ogawa N, Izawa T, Fukushima H (1994) Differential vasodilator properties of KRN2391, cromakalim, nitroglycerin and nifedipine in rabbit isolated femoral artery and vein. Br J Pharmacol 111:278–282
Takeda S, Inada Y, Tashiro N, Matsui K, Tomaru T, Negishi H, Hosoyamada A (1990) Hemodynamic features of hypotension induced by nicardipine in dogs (in Japanese with English abstract). Masui (Jpn J Anesthesiol) 39:1586–1596
Lagerkranser M (1982) Cardiovascular effects of nitroglycerin as a hypotensive agent in cerebral aneurysm surgery. Acta Anaesthesiol Scand 26:453–457
Takeuchi A, Harada K, Miwa A, Jinno Y, Kaneta S, Yokoyama T, Ogawa N (1994) Effect of KRN2391 on canine ventricular arrhythmia models. Gen Pharmacol 25:53–60
Seagard JL, Hopp FA, Donegan JH, Kalbfleisch JH, Kampine JP (1982) Halothane and the carotid sinus reflex: evidence for multiple sites of action. Anesthesiology 57:191–202.
Author information
Authors and Affiliations
About this article
Cite this article
Tashiro, N., Takeda, S. Possible evaluation of hemodynamic effects of the potassium channel opener KRN2391 on induced hypotension in dogs. J Anesth 11, 136–140 (1997). https://doi.org/10.1007/BF02480076
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02480076